SUPERNUS PHARMACEUTICALS, INC. Deferred Income Tax Assets, Net
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Deferred Income Tax Assets, Net of $49.06 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-03
- 2026-06-30: Deferred Income Tax Assets, Net $49.06M.
- 2026-03-31: Deferred Income Tax Assets, Net $30.82M.
- 2025-12-31: Deferred Income Tax Assets, Net $38.35M.
- 2025-09-30: Deferred Income Tax Assets, Net $8.79M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $49.06M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $30.82M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $38.35M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $8.79M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $6.18M 10-Q · filed 2025-08-05 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-02 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-08 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-17 |
| 2020-03-31 | $34.07M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $32.06M 10-K · filed 2021-03-08 |
| 2019-09-30 | $27.95M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $25.98M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $27.97M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $29.68M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |